231 related articles for article (PubMed ID: 11840381)
1. Dosage of potassium citrate in the correction of urinary abnormalities in pediatric distal renal tubular acidosis patients.
Domrongkitchaiporn S; Khositseth S; Stitchantrakul W; Tapaneya-olarn W; Radinahamed P
Am J Kidney Dis; 2002 Feb; 39(2):383-91. PubMed ID: 11840381
[TBL] [Abstract][Full Text] [Related]
2. The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis.
Tapaneya-Olarn W; Khositseth S; Tapaneya-Olarn C; Teerakarnjana N; Chaichanajarernkul U; Stitchantrakul W; Petchthong T
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1143-9. PubMed ID: 12549788
[TBL] [Abstract][Full Text] [Related]
3. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
4. Bone histology and bone mineral density after correction of acidosis in distal renal tubular acidosis.
Domrongkitchaiporn S; Pongskul C; Sirikulchayanonta V; Stitchantrakul W; Leeprasert V; Ongphiphadhanakul B; Radinahamed P; Rajatanavin R
Kidney Int; 2002 Dec; 62(6):2160-6. PubMed ID: 12427141
[TBL] [Abstract][Full Text] [Related]
5. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
Preminger GM; Sakhaee K; Pak CY
J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
[TBL] [Abstract][Full Text] [Related]
6. [Renal tubular function in children with hypercalciuria].
Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
[TBL] [Abstract][Full Text] [Related]
7. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
[TBL] [Abstract][Full Text] [Related]
8. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
Sakhaee K; Poindexter JR; Griffith CS; Pak CY
J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
[TBL] [Abstract][Full Text] [Related]
9. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
[TBL] [Abstract][Full Text] [Related]
10. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
Preminger GM; Sakhaee K; Skurla C; Pak CY
J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
[TBL] [Abstract][Full Text] [Related]
11. [Sodium excretion in children with lithogenic disorders].
Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
[TBL] [Abstract][Full Text] [Related]
12. Alkali absorption and citrate excretion in calcium nephrolithiasis.
Sakhaee K; Williams RH; Oh MS; Padalino P; Adams-Huet B; Whitson P; Pak CY
J Bone Miner Res; 1993 Jul; 8(7):789-94. PubMed ID: 8352061
[TBL] [Abstract][Full Text] [Related]
13. [Functional evaluation in patients with kidney calculi].
Stojimirović B
Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
[TBL] [Abstract][Full Text] [Related]
14. Urinary constituents in an endemic area of stones and renal tubular acidosis in northeastern Thailand.
Nilwarangkur S; Malasit P; Nimmannit S; Susaengrat W; Ong-Aj-Yooth S; Vasuvattakul S; Pidetcha P
Southeast Asian J Trop Med Public Health; 1990 Sep; 21(3):437-41. PubMed ID: 2075484
[TBL] [Abstract][Full Text] [Related]
15. Persistent and transient distal renal tubular acidosis with bicarbonate wasting.
Leumann EP; Steinmann B
Pediatr Res; 1975 Oct; 9(10):767-73. PubMed ID: 241961
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome in children with primary distal renal tubular acidosis.
Bajpai A; Bagga A; Hari P; Bardia A; Mantan M
Indian Pediatr; 2005 Apr; 42(4):321-8. PubMed ID: 15876593
[TBL] [Abstract][Full Text] [Related]
17. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
18. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
[TBL] [Abstract][Full Text] [Related]
19. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate.
Odvina CV; Mason RP; Pak CY
Am J Ther; 2006; 13(2):101-8. PubMed ID: 16645424
[TBL] [Abstract][Full Text] [Related]
20. [The significance of citrate, uromucoid and GAG for diagnosis of renal tubular acidosis in patients with urinary calculi].
Bichler KH; Henzler B; Strohmaier WL; Stahl C; Korn S
Urologe A; 1995 Nov; 34(6):437-43. PubMed ID: 8848853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
